About This Study
The purpose of this study is to learn more about a new medicine called cusatuzumab. We want to see if this medicine is safe and works well when given with usual medicines for a type of blood cancer called acute myeloid leukemia (AML). Volunteers in the study will get either the usual medicines or the usual medicines plus cusatuzumab. The goal is to find out which treatment helps patients more.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Charlotte, NC
- Greater Winston-Salem, NC